A widely used guideline said I didn’t need a mammogram. It was wrong

Thursday, October 11, 2018

Stat News (10/11, Dederich ) The existence of multiple and conflicting breast cancer screening guidelines for women between the ages of 40 and 49 can do real harm.

DBT Plus ABVS Offers a Breast Cancer Staging Alternative

Wednesday, October 10, 2018

Aunt Minnie (10/10, Yee) Combined digital breast tomosynthesis (DBT) and ultrasound automated breast volume scanning (ABVS) performs comparably to MRI when it comes to staging breast cancer, according to a study published in the October issue of the European Journal of Radiology.

Almost 25% of women pay out-of-pocket costs for mammography

Wednesday, October 10, 2018

Aunt Minnie (10/10, Yee) Nearly a quarter of U.S. women continue to have out-of-pocket costs for screening mammography, despite the fact that the Affordable Care Act of 2010 (ACA) removed cost-sharing barriers for such preventive services, according to a study published online September 28 in the Journal of Women's Health.

Society of Breast Imaging partners with Oxford University Press to publish Journal of Breast Imaging

Wednesday, October 10, 2018

The Society of Breast Imaging (SBI) and Oxford University Press (OUP) are pleased to announce their partnership to publish Journal of Breast Imaging (JBI), the first peer-reviewed journal to focus solely on breast imaging.

JBI is a peer-reviewed publication that aims to provide high quality, evidence-based content for the global breast imaging medical community. The journal seeks to advance the field of breast imaging, with particular focus on improving patient care and outcomes. JBI will publish original research, as well as reviews of important scientific, educational, and clinical topics.

“It’s an honor to oversee the launch of JBI,” says Jennifer A. Harvey, MD, FACR, FSBI, JBI’s Editor-in-Chief. “The journal will provide a focused platform to disseminate scholarly work, as well as practical articles on breast cancer screening, clinical practice aspects of breast imaging, and educational opportunities, with the goal of advancing the global field of breast imaging for the betterment of patient care.”

SBI’s mission since its inception in 1985 has been to save lives and minimize the impact of breast cancer. JBI is uniquely positioned to advance this mission, according to Jay A. Baker, MD, FACR, FSBI, the Society’s President: “Despite the importance of breast imaging in the lives of countless women – and more than a few men – physicians and scientists seeking new information about the science and clinical practice of breast imaging have had to rely on the relatively few studies found in general interest journals. As the official journal of the Society of Breast Imaging, JBI solves this problem by providing a home for the latest research and clinical guidance for those who practice and those who study all facets of breast imaging.”

Alison Denby, publishing director for Oxford Journals, said, “We’re looking forward to working with SBI to launch this much needed outlet for research in breast imaging. SBI is an engaged, dedicated group and we are committed to working together for this journal’s success.”

About Oxford University Press

Oxford University Press publishes over 400 academic and research journals covering a broad range of subject areas, two thirds of which are published in collaboration with learned societies and other international organizations. Oxford University Press has been publishing journals for more than a century and, as the world's largest university press, has more than 500 years of publishing expertise.

Can Dedicated Breast PET Identify Suspicious Lesions?

Tuesday, October 9, 2018

Aunt Minnie (10/9) In a group of 50 patients with mammograms classified as BI-RADS 4, dedicated breast PET missed nine of 18 cancers. In addition, dedicated breast PET recorded increased metabolic activity in 10 benign lesions.

"Our analysis does not allow the recommendation of dedicated breast PET for diagnosis of malignancy in BI-RADS 4 mammographic or ultrasound abnormalities, given the high rate of false-negative results regarding in situ neoplasms," wrote lead author Dr. Lucía Graña-López from Hospital Lucus Augusti Lugo and colleagues.